Skip to content
PubMed This is a summary of 47 peer-reviewed journal articles Updated
Hematology

Severe Congenital Neutropenia due to JAGN1 Deficiency: A Patient Guide

At a Glance

JAGN1-related severe congenital neutropenia is a rare inherited disorder that reduces infection-fighting white blood cells and their function. Care focuses on prompt infection evaluation, dental protection, G-CSF treatment, and specialist monitoring; a bone marrow transplant may help some children.

Severe congenital neutropenia (SCN) due to JAGN1 deficiency is an exceptionally rare genetic condition that affects how the body produces and uses neutrophils, the white blood cells responsible for being the first responders to bacterial and fungal infections. In children with this diagnosis, the “factory” in the bone marrow faces a biological hurdle: it struggles to mature these cells, and the few that do reach the bloodstream often lack the necessary tools to fight germs effectively. Because this is an autosomal recessive condition, it is usually inherited from two healthy parents who each carry one copy of the changed gene, often without any prior family history of the disease [1][2]. Genetic counseling can help families understand carrier testing, recurrence risk, and options for siblings or future pregnancies.

Living with JAGN1-SCN means remaining vigilant against infections that can become serious very quickly. While many children experience frequent skin abscesses or respiratory issues, the condition also specifically affects the mouth and gums, leading to severe dental disease that requires early and aggressive intervention. Some children may also experience “syndromic” features, such as slower physical growth or developmental delays, which are often linked to specific variations in the JAGN1 gene. Understanding these diverse symptoms helps a care team tailor monitoring to each child’s unique needs [3][4].

The pillars of managing this condition focus on boosting the immune system and guarding against long-term risks. Most children receive daily injections of a medicine called G-CSF to help the bone marrow produce more neutrophils, though JAGN1 patients often require higher amounts of this medicine than those with other forms of neutropenia. For children whose condition does not respond well to medicine or who face life-threatening complications, a bone marrow transplant offers a potential correction for the blood-related symptoms. Throughout this journey, regular bone marrow check-ups are essential to ensure the “factory” remains healthy and to catch any cellular changes as early as possible [5][6].

While a diagnosis of JAGN1-SCN brings significant changes to daily life, it also brings a clear path for specialized care. Modern medicine provides the tools to manage infections, protect dental health, and monitor long-term safety with precision. By working closely with a team of experts—including hematologists, immunologists, and specialized dentists—parents can provide their children with the protection they need while focusing on the joy of their growth and development through childhood and into adulthood [7][8].

Common questions in this guide

How does JAGN1 deficiency lead to severe congenital neutropenia?
Changes in the JAGN1 gene can interfere with the bone marrow’s ability to mature neutrophils and can also affect how these cells fight germs. The condition is usually inherited in an autosomal recessive pattern, so a child generally receives a changed copy from each parent, who may be healthy carriers.
What health problems can children with JAGN1-SCN develop?
Children may have serious infections, including frequent skin abscesses and respiratory problems. Severe disease of the teeth and gums is an important feature, and some children may also have slower growth or developmental delays.
How does G-CSF treatment help a child with JAGN1-SCN?
G-CSF is given as an injection to encourage the bone marrow to produce more neutrophils. Children with JAGN1-SCN often need higher doses than people with other forms of neutropenia, so the care team monitors whether treatment is providing enough protection.
When might a bone marrow transplant be considered?
A bone marrow transplant may be considered when the condition responds poorly to G-CSF or causes life-threatening complications. A specialist team weighs whether transplantation is appropriate for the child and explains its potential benefits and risks.
Why is dental care especially important in JAGN1-SCN?
JAGN1-SCN can seriously affect the mouth and gums and may lead to severe dental disease. Early, intensive dental care and coordination between the dental and medical teams can help protect oral health.
What should families do if a child with JAGN1-SCN develops a fever?
Families should obtain a written fever plan from the child’s care team because infections can become serious quickly. The plan should explain whom to contact and where to seek urgent evaluation, and families should follow those instructions rather than waiting for symptoms to worsen.

Get notified when new evidence is published on Severe congenital neutropenia due to JAGN1 deficiency.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (8)
  1. 1

    Case report: Granulocyte-macrophage colony-stimulating factor sargramostim did not rescue the neutrophil phenotype in two patients with JAGN1-mutant severe congenital neutropenia.

    Farmand S, Aydin SE, Wustrau K, et al.

    Frontiers in immunology 2024; (15()):1373495 doi:10.3389/fimmu.2024.1373495.

    PMID: 39286252
  2. 2

    Jagunal homolog 1 safeguards neutrophil immune function by preserving protein sialylation during differentiation.

    Nussbaumer K, Hübner M, da Costa R, et al.

    Blood advances 2026; (10(21)):7311-7324 doi:10.1182/bloodadvances.2026019794.

    PMID: 42685351
  3. 3

    Extended clinical phenotypes and treatment modalities in 32 JAGN1-deficient patients: a multicenter study by ESID and EBMT IEWP.

    Fekadu-Siebald J, Salzmann-Manrique E, Heusel JR, et al.

    Blood advances 2025; (9(7)):1702-1711 doi:10.1182/bloodadvances.2024014344.

    PMID: 39775668
  4. 4

    Chronic neutropenia: how best to assess severity and approach management?

    Donadieu J, Frenz S, Merz L, et al.

    Expert review of hematology 2021; (14(10)):945-960 doi:10.1080/17474086.2021.1976634.

    PMID: 34486458
  5. 5

    Severe congenital neutropenias.

    Skokowa J, Dale DC, Touw IP, et al.

    Nature reviews. Disease primers 2017; (3()):17032 doi:10.1038/nrdp.2017.32.

    PMID: 28593997
  6. 6

    HSCT may lower leukemia risk in ELANE neutropenia: a before-after study from the French Severe Congenital Neutropenia Registry.

    Rotulo GA, Beaupain B, Rialland F, et al.

    Bone marrow transplantation 2020; (55(8)):1614-1622 doi:10.1038/s41409-020-0800-1.

    PMID: 31992846
  7. 7

    Family Knowledge, Attitudes, and Practices Toward Severe Congenital Neutropenia.

    Karadaş N, Yilmaz Y, Önen Göktepe Ş, et al.

    Journal of pediatric hematology/oncology 2023; (45(4)):e441-e445 doi:10.1097/MPH.0000000000002634.

    PMID: 36897312
  8. 8

    Manifestation of severe congenital neutropenia in the oral cavity. Case report.

    Krasuska-Sławińska E, Klaudel-Dreszler M, Minota M, et al.

    Central-European journal of immunology 2013; (48(1)):70-74 doi:10.5114/ceji.2023.125312.

    PMID: 37206584

This page is for informational purposes only and does not constitute medical advice about your child’s JAGN1-related neutropenia. Your child’s hematology, immunology, genetics, and dental teams should tailor infection plans, treatment, and monitoring.